These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17611627)

  • 21. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis.
    Lynch J; Peeling J; Auty A; Sutherland GR
    Can J Neurol Sci; 1993 Aug; 20(3):194-8. PubMed ID: 8221382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
    PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
    J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
    PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
    Kuenz B; Lutterotti A; Ehling R; Gneiss C; Haemmerle M; Rainer C; Deisenhammer F; Schocke M; Berger T; Reindl M
    PLoS One; 2008 Jul; 3(7):e2559. PubMed ID: 18596942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
    Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
    Rot U; Mesec A
    Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
    Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
    Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis.
    Dujmovic I; Pekmezovic T; Obrenovic R; Nikolić A; Spasic M; Mostarica Stojkovic M; Drulovic J
    Clin Chem Lab Med; 2009; 47(7):848-53. PubMed ID: 19496733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid.
    Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI
    Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
    Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
    Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.